Skip to main content
Clinical Trials/NL-OMON27218
NL-OMON27218
Completed
Not Applicable

Diagnostic accuracy of minimally-invasive biomarkers for sputum eosinophilia in adult-onset asthma patients.

Academic Medical Center, Amsterdam0 sites336 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
adult-onset asthmasputum eosinophilia
Sponsor
Academic Medical Center, Amsterdam
Enrollment
336
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Academic Medical Center, Amsterdam

Eligibility Criteria

Inclusion Criteria

  • Age: 18\-75 years
  • Physician’s diagnosis of asthma, combined with documented reversibility in FEV1 of \> 12% of predicted value or a positive inhaled methacholine provocation test (PC20 \< 8mg/ml) or diurnal variation in PEF of \>20% (with twice daily reading \>10%)

Exclusion Criteria

  • Smoking history of \>10 pack years combined with fixed airflow obstruction (FEV1 \<80% of predicted and FEV1/FVC \<0\.70\) without reversibility in FEV1 \<12% or with a diffusion capacity \<80% (TLCO/VA).
  • Other pulmonary diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials